23 February 2022 | News
Dr Egros will lead the development and execution of the company’s inorganic growth strategy
Image credit: https://www.lupin.com
Dr Fabrice Egros has assumed responsibilities for Global Corporate Development as President, Corporate Development and Growth Markets for Lupin. Dr Egros takes over the Corporate Development role from Alan Butcher departing from the company on February 28, 2022. Dr Egros will lead the development and execution of the company’s inorganic growth strategy, including mergers and acquisitions, business development, in-licensing arrangements, and related matters. He will continue to lead the business in LATAM and Asia regions in this new role.
For the past six years, Dr Egros has played an integral role in Lupin, leading businesses across both growth and developed markets.